Jain S - Search Results

1

Characterizing HIV transmission networks across the United States.

Aldous JL, Pond SK, Poon A, Jain S, Qin H, Kahn JS, Kitahata M, Rodriguez B, Dennis AM, Boswell SL, Haubrich R, Smith DM. Aldous JL, et al. Among authors: jain s. Clin Infect Dis. 2012 Oct;55(8):1135-43. doi: 10.1093/cid/cis612. Epub 2012 Jul 10. Clin Infect Dis. 2012. PMID: 22784872 Free PMC article.

2

A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patients.

Best BM, Goicoechea M, Witt MD, Miller L, Daar ES, Diamond C, Tilles JG, Kemper CA, Larsen R, Holland DT, Sun S, Jain S, Wagner G, Capparelli EV, McCutchan JA, Haubrich RH; California Collaborative Treatment Group 578 Study Team. Best BM, et al. Among authors: jain s. J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):433-42. doi: 10.1097/QAI.0b013e318156f029. J Acquir Immune Defic Syndr. 2007. PMID: 17786128 Clinical Trial.

3

Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy.

Goicoechea M, Liu S, Best B, Sun S, Jain S, Kemper C, Witt M, Diamond C, Haubrich R, Louie S; California Collaborative Treatment Group 578 Team. Goicoechea M, et al. Among authors: jain s. J Infect Dis. 2008 Jan 1;197(1):102-8. doi: 10.1086/524061. J Infect Dis. 2008. PMID: 18171292 Clinical Trial.

4

Interlaboratory measurement differences in intracellular carbovir triphosphate concentrations in HIV-infected patients: sources of variability in processing, shipping, and quantitation.

Goicoechea M, Jain S, Bi L, Sun S, Smith G, Ha B, Richman D, Louie S, Haubrich R; California Collaborative Treatment Group. Goicoechea M, et al. Among authors: jain s. J Clin Pharmacol. 2010 Aug;50(8):968-74. doi: 10.1177/0091270009352186. Epub 2009 Dec 1. J Clin Pharmacol. 2010. PMID: 19952374 No abstract available.

5

Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patients.

Goicoechea M, Jain S, Bi L, Kemper C, Daar ES, Diamond C, Ha B, Flaherty J, Sun S, Richman D, Louie S, Haubrich R; California Collaborative Treatment Group. Goicoechea M, et al. Among authors: jain s. AIDS. 2010 Mar 13;24(5):707-16. doi: 10.1097/QAD.0b013e32833676eb. AIDS. 2010. PMID: 20087154 Clinical Trial.

6

High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study.

Innes S, Cotton MF, Haubrich R, Conradie MM, van Niekerk M, Edson C, Rabie H, Jain S, Sun X, Zöllner EW, Hough S, Browne SH. Innes S, et al. Among authors: jain s. BMC Pediatr. 2012 Nov 23;12:183. doi: 10.1186/1471-2431-12-183. BMC Pediatr. 2012. PMID: 23176441 Free PMC article.

7

Biceps skin-fold thickness may detect and predict early lipoatrophy in HIV-infected children.

Innes S, Schulte-Kemna E, Cotton MF, Zöllner EW, Haubrich R, Klinker H, Sun X, Jain S, Edson C, van Niekerk M, Innes ER, Rabie H, Browne SH. Innes S, et al. Among authors: jain s. Pediatr Infect Dis J. 2013 Jun;32(6):e254-62. doi: 10.1097/INF.0b013e3182814b30. Pediatr Infect Dis J. 2013. PMID: 23249919 Free PMC article.

8

Factors associated with high transmission risk and detectable plasma HIV RNA in HIV-infected MSM on ART.

Blumenthal J, Haubrich R, Jain S, Sun X, Dube M, Daar E, Milam J, Morris S. Blumenthal J, et al. Among authors: jain s. Int J STD AIDS. 2014 Sep;25(10):734-41. doi: 10.1177/0956462413518500. Epub 2014 Jan 22. Int J STD AIDS. 2014. PMID: 24452730 Free PMC article.

9

Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expression.

Beliakova-Bethell N, Jain S, Woelk CH, Witt MD, Sun X, Lada SM, Spina CA, Goicoechea M, Rought SE, Haubrich R, Dubé MP. Beliakova-Bethell N, et al. Among authors: jain s. Antiviral Res. 2014 Jul;107:42-9. doi: 10.1016/j.antiviral.2014.04.005. Epub 2014 Apr 24. Antiviral Res. 2014. PMID: 24769244 Free PMC article.

10

Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP.

Blumenthal J, Jain S, Krakower D, Sun X, Young J, Mayer K, Haubrich R; CCTG 598 Team. Blumenthal J, et al. Among authors: jain s. AIDS Behav. 2015 May;19(5):802-10. doi: 10.1007/s10461-015-0996-z. AIDS Behav. 2015. PMID: 25616837 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,016 results

Search Page

Filters